Example collocations logo

Antimicrobial in sentence

94 examples of Antimicrobial in a sentence

Now, that little spider happens to produce amazingly powerful antimicrobial compounds.
It's referred to as "Antimicrobial Resistance."
The US Centers for Disease Control and Prevention call antimicrobial resistance one of the greatest public health challenges of our time.
The pharmaceutical industry is rushing to develop more and more and more antimicrobials, desperately trying to outpace antimicrobial resistance.
It's clear the antimicrobial era is coming to an end, so we have to think about this in a whole new way.
And nearly 1500 years later, Alexander Fleming discovered the antimicrobial properties of mold.
I hope to encourage Chinese policymakers to make the fight against antimicrobial resistance a priority when China chairs the G-20 in 2016.
First, some technological pessimists – such as Northwestern University’s Robert Gordon – argue that the economic impact of recent innovations pales in comparison to that of the great innovations of the First and Second Industrial Revolutions (the steam engine, electricity, piped water and sanitation, antimicrobial drugs, and so on).
Tracking Big Pharma’s Progress on AMRLONDON – This week, at the World Economic Forum’s annual meeting in Davos, the Access to Medicine Foundation (AMF) is launching an antimicrobial resistance (AMR) benchmark to “track how pharmaceutical companies are responding to the increase in drug-resistance.”
These pockets of the bacterium, now completely immune to antimicrobial treatment, mean that the challenge of global eradication has become even more daunting.
I learned about one example when discussing antimicrobial resistance, to which the government has responded by attempting to limit the quantity of antibiotics a patient may take.
But despite the paucity of success, the typical goal in cancer therapy remains similar to that of antimicrobial treatments – killing as many tumor cells as possible under the assumption that this will, at best, cure the disease and, at worst, keep the patient alive for as long as possible.
And measures used to mitigate that risk, such as the administration of low doses of antibiotics to prevent disease (and promote growth), are creating a public-health crisis by strengthening resistance to antimicrobial drugs.
Unless action is taken, antimicrobial resistance will kill ten million people a year by 2050 – more than the number of people who currently die from cancer.
The Review is studying ways to align financial incentives for developing new antimicrobial drugs more closely with these medicines’ true social value.
In its most recent paper, the Review has identified specific measures that could provide a starting point for the fight against antimicrobial resistance.
Evidence seems to show that young scientists and doctors are reluctant to enter fields related to antimicrobial resistance.
In the coming months, I will travel to India and China to discuss antimicrobial resistance with senior policymakers and companies.
By 2050, antimicrobial resistance could impose a cumulative economic cost of $20 trillion on China – equivalent to about two years of its current GDP.
It is statistics like these that have led me to conclude that the fight against antimicrobial resistance must be placed high on the G-20’s agenda.
The Economic Consequences of Drug ResistanceLONDON – When British Prime Minister David Cameron asked me in July to lead an effort to find solutions to the growing global problem of antimicrobial resistance, my first question was: “What is that?”
It turns out that the problem of rising antimicrobial resistance is as much about economics as it is about science or medicine.
Recent research, by an independent review on antimicrobial resistance, which I chair, has modeled the phenomenon’s likely impact on the world economy.
It suggests that if we fail to address antimicrobial resistance, the problem will grow worse.
Already, 60,000 people die every year from causes related to antimicrobial resistance in the United States and Europe – some ten times the worldwide death toll from the ongoing Ebola crisis.
By 2050, if the problem is allowed to continue to grow, antimicrobial resistance will kill more than ten million people per year.
Rising rates of antimicrobial resistance will have a particularly severe impact on India, Indonesia, and Nigeria (as well as the rest of Sub-Saharan Africa).
One of my goals is to persuade policymakers at the United Nations to agree to a set of rules and policies to stop the growth of antimicrobial resistance.
As the review research shows, the stakes of inaction on antimicrobial resistance are high.
Among the many global problems today, the fight against antimicrobial resistance (AMR) desperately needs a similar breakthrough commitment.
Next